Core Viewpoint - Urumqi, as the capital of Xinjiang Uygur Autonomous Region, is a strategic hub for the "Belt and Road" initiative and is focusing on building a modern industrial system through the "Industrial Strong City" strategy, emphasizing advanced manufacturing, modern services, and urban agriculture [1][4][15]. Group 1: Economic Performance - Urumqi's GDP for 2024 is projected to reach 450.216 billion yuan, with a year-on-year growth of 5.3%, surpassing the national average [4][5]. - The primary industry is expected to achieve an added value of 32.47 billion yuan, growing by 6.6%; the secondary industry is projected to reach 1,327.33 billion yuan, with a growth of 10.8%; and the tertiary industry is anticipated to add 3,142.36 billion yuan, growing by 3.3% [5][7]. Group 2: Industrial Development - Urumqi is implementing the "5+2" modern industrial system, focusing on energy and chemical, equipment manufacturing, new materials, biomedicine, and electronic information, along with emerging industries like new energy and environmental protection [15][17]. - The city has seen a significant increase in industrial investment, with 138 industrial projects attracting a total investment of 105.66 billion yuan, marking a 25.8% increase year-on-year [7][9]. Group 3: New Quality Productive Forces - The concept of "New Quality Productive Forces" emphasizes innovation-driven development, characterized by high-tech, high-efficiency, and high-quality production, aligning with the new development philosophy [2][3][11]. - Urumqi is actively responding to national strategies by implementing policies that encourage the development of modern agriculture, green energy, and cultural tourism, among others [11][12]. Group 4: Policy Framework - The Urumqi government has introduced several policies to support the growth of new industries, including financial incentives for high-tech enterprises and measures to promote the development of industrial parks [11][12]. - The "Western Region Encouraged Industry Directory" has added 57 new encouraged industry items for Xinjiang, covering modern agriculture, green energy, and textile industries, providing strong policy support for regional industrial upgrades [11][12]. Group 5: Future Trends - Urumqi is focusing on high-end manufacturing and new material clusters, aiming to create three trillion-level advanced manufacturing clusters by 2025 [28][29]. - The city is also building a future industry ecosystem driven by "three new" initiatives, including commercial aerospace and low-altitude economy [30]. - Urumqi is committed to a green low-carbon transformation, with plans to increase the share of new energy installations to over 50% by 2025 [31].

Core Viewpoint - The company has announced its 2024 annual profit distribution plan, which includes a cash dividend of 2.2 RMB per 10 shares, approved by the shareholders' meeting held on May 20, 2025 [1]. Summary by Sections Profit Distribution Plan - The profit distribution plan is based on a total share capital of 1,365,251,515 shares, with a cash dividend of 2.2 RMB per 10 shares (tax included) [1]. - No capital reserve will be converted into share capital, and no bonus shares will be issued [1]. Dividend Taxation - For Hong Kong market investors and overseas institutions, the cash dividend will be 1.98 RMB per 10 shares after tax [1]. - Different tax rates will apply for individual shareholders based on the holding period of their shares, with specific amounts for different durations [2]. Key Dates - The record date for the distribution is set for June 4, 2025, and the ex-dividend date is June 5, 2025 [1]. Distribution Method - Cash dividends will be directly credited to the shareholders' accounts through their securities companies or other custodians [1][2]. Consultation Information - The company provides contact details for inquiries regarding the distribution plan, including a specific address and phone numbers [3].

天康生物 证券代码：002100 证券简称：天康生物 公告编号：2025-034 天康生物股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 天康生物股份有限公司(以下简称"公司")2024年年度权益分派方案已获2025 年 5 月 20 日召开的 2024 年年度股东大会审议通过，现将权益分派事宜公告如下： 一、股东大会审议通过利润分配方案的情况 1、2025 年 5 月 20 日，公司召开 2024 年年度股东大会审议通过了《关于 2024 年度利润分配预案的议案》。以公司总股本 1,365,251,515 股为基数，向全体股 东每 10 股派发现金红利 2.2 元（含税），本次利润分配不进行资本公积转增股本， 不送红股。董事会、股东大会审议利润分配预案后至实施权益分派股权登记日期 间，如享有利润分配权的股份总数发生变动，则以未来实施分配方案时股权登记 日享有利润分配权的股份总数为基数，按照分配比例不变的原则进行调整。 本公司 2024 年年度权益分派方案为：以公司现有总股本 1,365,251,515 股为 基 ...

Group 1 - The China Livestock Breeding Index (930707) increased by 0.05% as of May 27, 2025, with notable gains from companies such as Ruip Bio (300119) up 1.68% and Yike Food (301116) up 1.44% [1] - The Livestock ETF (516760) rose by 0.16%, with a latest price of 0.63 yuan, and has accumulated a 0.64% increase over the past two weeks [1] - The Livestock ETF has shown a net value increase of 3.27% over the past six months, with a maximum single-month return of 17.22% since its inception [1] Group 2 - Sichuan Province has drafted ten measures to promote high-quality development in the livestock industry, focusing on strengthening leading enterprises and supporting their participation in large-scale projects [2] - The measures aim to enhance the capabilities of leading livestock enterprises to drive the development of farms and households [2] Group 3 - Short-term pig prices are expected to remain stable, with a balanced supply-demand situation anticipated in the second half of the year, leading to a more optimistic outlook for pig price expectations and profitability of pig enterprises [3] - Current pig prices allow for slight profitability for breeding enterprises, but the industry faces challenges in capacity reduction, with cost competition becoming a key focus [3] Group 4 - As of May 26, 2025, the Livestock ETF has experienced a maximum drawdown of 5.00% this year, with a management fee of 0.50% and a custody fee of 0.10% [5] - The Livestock ETF tracks the China Livestock Breeding Index, which has a current price-to-earnings ratio (PE-TTM) of 12.33, indicating a historical low valuation [5] - The top ten weighted stocks in the China Livestock Breeding Index account for 69.38% of the index, with companies like Haida Group (002311) and Muyuan Foods (002714) being the largest contributors [5]

Group 1: Company Financials and Plans - The company currently has no share repurchase plan but will disclose any future plans in accordance with regulations [2] - As of May 20, 2025, the number of shareholders is 73,557 [3] - The company achieved a net profit of 148 million yuan in Q1 2025 and aims to meet its annual business targets [5] Group 2: Dividend and Profit Distribution - There is no mid-term dividend plan for 2025 as of now [2] - The profit distribution for 2024 will be implemented within two months after the annual shareholders' meeting [3] Group 3: Business Operations and Market Strategy - The company is focused on feed production, veterinary drug development, pig farming, and agricultural product processing, with no current plans to enter the pet economy [3] - The company plans to raise its pig output from 3.0285 million heads in 2024 to between 3.5 million and 4 million heads in 2025 [5] Group 4: Management and Incentive Policies - The increase in management expenses from 487 million yuan in 2023 to 560 million yuan in 2024 is due to depreciation from newly added fixed assets, not due to increased management salaries [3] - The company is reviewing its incentive policies to ensure they align with shareholder interests, especially in light of recent losses [6] Group 5: Market and Shareholder Communication - The company emphasizes value management through shareholding increases by major shareholders and improved governance and communication with investors [4] - The company is in the process of listing its pharmaceutical division on the Beijing Stock Exchange, with timelines dependent on regulatory reviews [5]

天康生物 证券代码：002100 证券简称：天康生物 公告编号：2025-033 天康生物股份有限公司 关于控股股东增持公司股份计划实施完成 公司控股股东新疆生产建设兵团国有资产经营有限责任公司保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： ? 增持计划：天康生物股份有限公司（以下简称"公司"）控股股东新疆生 产建设兵团国有资产经营有限责任公司（以下简称"兵团国资公司"）计划自 2024 年 11 月 20 日起 6 个月内增持本公司股份，计划增持金额不少于人民币 10,000 万 元，不超过人民币 20,000 万元，本次增持不设定价格区间。 ? 增持进展：截至 2025 年 5 月 19 日暨本次增持计划实施期限届满，兵团国 资公司通过深圳证券交易所交易系统以集中竞价方式增持公司股份 24,321,903 股，占公司总股本的 1.78%，增持金额为 159,890,689.93 元，达到增持计划下限 金额，且未超上限，本次增持计划实施完毕。本次增持后，兵团国资公司持有公 司股份 318,90 ...

本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 天康生物 证券代码：002100 证券简称：天康生物 公告编号：2025-033 天康生物股份有限公司 关于控股股东增持公司股份计划实施完成 暨增持股份达到 1%的公告 公司控股股东新疆生产建设兵团国有资产经营有限责任公司保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 增持计划：天康生物股份有限公司（以下简称"公司"）控股股东新疆生 产建设兵团国有资产经营有限责任公司（以下简称"兵团国资公司"）计划自 2024 年 11 月 20 日起 6 个月内增持本公司股份，计划增持金额不少于人民币 10,000 万 元，不超过人民币 20,000 万元，本次增持不设定价格区间。 增持进展：截至 2025 年 5 月 19 日暨本次增持计划实施期限届满，兵团国 资公司通过深圳证券交易所交易系统以集中竞价方式增持公司股份 24,321,903 股，占公司总股本的 1.78%，增持金额为 159,890,689.93 元，达到增持计划下限 金额，且未超上限，本次增持计划实施完毕。本次增持后，兵团国资公司持有公 ...

Core Viewpoint - The company TianKang Biological (002100) announced that its controlling shareholder, Xinjiang Production and Construction Corps State-owned Assets Management Co., Ltd., has completed its shareholding increase plan, acquiring a total of 24.32 million shares, which represents 1.78% of the company's total share capital, for an amount of 160 million yuan [1] Summary by Relevant Categories Shareholding Increase - The controlling shareholder increased its stake by acquiring 24.32 million shares through the Shenzhen Stock Exchange, representing 1.78% of the total share capital [1] - The total amount spent on this share acquisition was 160 million yuan [1] Current Shareholding Structure - After the completion of the shareholding increase, the state-owned assets management company holds a total of 319 million shares in the company, which corresponds to a holding ratio of 23.36% [1]

天康生物 2024 年年度股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 重要提示： 1、本次股东大会无增加、变更、否决提案的情况； 2、本次股东大会未涉及变更以往股东大会已通过决议的情况。 一、 会议召开和出席情况 （一）会议召开时间 证券代码：002100 证券简称：天康生物 公告编号：2025-032 天康生物股份有限公司 天康生物 现场会议时间：2025 年 5 月 20 日上午 11：00 时 网络投票时间：2025 年 5 月 20 日，其中，通过深圳证券交易所交易系统进 行网络投票的具体时间为 2025 年 5 月 20 日上午 9:15—9:25，9:30—11:30 和下 午 13:00-15:00；通过深圳证券交易所互联网投票系统进行网络投票的具体时间 为 2025 年 5 月 20 日上午 9：15 至下午 15:00 任意时间。 （二）会议召开地点：新疆乌鲁木齐市高新区长春南路 528 号天康企业大 厦 11 楼公司 4 号会议室。 （三）会议召开方式：现场投票与网络投票相结合的方式。 （四）会议召集人：公司董事会 （五 ...

天康生物 2024 年年度股东大会法律意见书 新疆星河井然律师事务所 关于天康生物股份有限公司 为出具本法律意见书，本所律师对公司本次会议所涉及的有关事项进 行了审查，查阅了本所律师认为出具本法律意见书所必须查阅的文件，并 对有关问题进行了必要的核查和验证。 本法律意见书仅供本次会议见证之目的使用，不得用作其他任何目的。 本所律师同意将本法律意见书随公司本次会议决议一起公告，并依法 对本法律意见书承担相应的责任。 本所律师根据相关法律、法规和规范性文件的要求，按照律师行业公 认的业务标准、道德规范和勤勉尽责精神，出具法律意见如下： 2024 年年度股东大会之 法律意见书 星河证股字[2025]第 004 号 致：天康生物股份有限公司 新疆星河井然律师事务所（以下简称"本所"）接受天康生物股份有 限公司（以下简称"公司"）委托，指派律师出席公司 2024 年年度股东 大会（以下简称"本次会议"），并根据《中华人民共和国证券法》（以 下简称"《证券法》"）、《中华人民共和国公司法》（以下简称"《公 司法》"）、《上市公司股东大会规则》（以下简称"《规则》"）、《深 圳证券交易所股票上市规则》（以下简称"《上市规则 ...